EXEL: the balance sheet

MyFinsight

For the quarter ending 2025-10-03, EXEL has $2,823,547K in assets. $662,847K in debts. $376,300K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
375.16%
Quick Ratio
367.83%
Cash Ratio
100.68%
Debt to Asset Ratio
23.48%
Assets Breakdown
Marketable securities
Non-current marketable securitie...
Deferred tax assets, net
Others
Liabilities Breakdown
Additional paid-in-capital
Non-current operating lease liab...
Other non-current liabilities
Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-10-03	2025-07-04	2025-04-04	2024-09-27
Cash and cash equivalents	376,300	164,433	183,752	258,346
Marketable securities	612,235	626,665	847,564	930,815
Trade receivables, net	309,725	292,354	281,637	269,706
Inventory	27,402	23,483	24,853	21,013
Prepaid expenses and other current assets	76,595	73,829	58,696	69,838
Total current assets	1,402,257	1,180,764	1,396,502	1,549,718
Non-current marketable securities	578,287	594,652	619,441	523,421
Property and equipment, net	104,748	110,314	115,030	124,414
Deferred tax assets, net	418,582	419,241	419,045	358,869
Goodwill	63,684	63,684	63,684	63,684
Right-of-use assets and other non-current assets	255,989	309,426	223,545	340,170
Total assets	2,823,547	2,678,081	2,837,247	2,960,276

Accounts payable	25,348	25,821	42,840	59,309
Accrued compensation and benefits	104,364	72,250	89,747	90,605
Accrued clinical trial liabilities	57,781	57,874	57,635	56,184
Rebates and fees due to customers	58,234	57,276	57,840	62,495
Accrued collaboration liabilities	23,428	21,525	25,489	30,030
Other current liabilities	104,622	101,365	125,551	95,723
Total current liabilities	373,777	336,111	399,102	394,346
Non-current operating lease liabilities	176,463	179,842	187,125	194,445
Other non-current liabilities	112,607	128,592	119,996	96,066
Total liabilities	662,847	644,545	706,223	684,857
Common stock, 0.001 par value 400,000 shares authorized issued and outstanding 268,098 and 281,732 at september30, 2025, and december31, 2024, respectively	268	270	275	286
Additional paid-in-capital	2,262,928	2,251,456	2,292,033	2,361,470
Accumulated other comprehensive income (loss)	3,565	1,349	2,010	3,956
Accumulated deficit	-106,061	-219,539	-163,294	-90,293
Total stockholders equity	2,160,700	2,033,536	2,131,024	2,275,419
Total liabilities and stockholders equity	2,823,547	2,678,081	2,837,247	2,960,276

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Current Ratio375.16%Quick Ratio367.83%Cash Ratio100.68%Debt to Asset Ratio23.48%Assets BreakdownMarketable securitiesNon-current marketable securitie...Deferred tax assets, netOthersLiabilities BreakdownAdditional paid-in-capitalNon-current operating lease liab...Other non-current liabilitiesOthers

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Current Ratio375.16%Quick Ratio367.83%Cash Ratio100.68%Debt to Asset Ratio23.48%Assets BreakdownMarketable securitiesNon-current marketable securitie...Deferred tax assets, netOthersLiabilities BreakdownAdditional paid-in-capitalNon-current operating lease liab...Other non-current liabilitiesOthers

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets